Comments
Bal Pharma’s net profits have declined by 53.56 per cent at Rs 1.63 crore for the quarter ended March 31, 2012 as compared to corresponding quarter of last year.
The company’s revenues are marginally higher by 4.76 per cent to Rs 39.76 crore for quarter ended March 31, 2012 as against Rs 37.95 crore in the same period previous year.
Earnings per share (EPS) after extraordinary items stood at Rs 1.54 as against Rs 3.35 registered in the same period last year.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.